Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Boris Kerzner"'
Autor:
Keith S. Reisinger, Jon E. Stek, Janie Parrino, Alexander V Murray, Jin Xu, Boris Kerzner, Paula W. Annunziato, Ivan S. F. Chan, Timothy A. Sausser, William Wang
Publikováno v:
Human Vaccines. 7:1130-1136
To evaluate the general safety of zoster vaccine (ZV) in adults ≥60 years old.Subjects were enrolled in a 1:1 ratio to receive 1 dose of ZV or placebo. Subjects were followed for serious adverse experiences (SAEs) for 42 days (primary follow-up per
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae75cbec06156006e1cff5588a7563b0
https://doi.org/10.4161/hv.7.11.17982
https://doi.org/10.4161/hv.7.11.17982
Autor:
Brian K. Roberts, Thomas W. Littlejohn, Yun-Jung Choi, David B. Karpf, Ronald M. Krauss, Sue Naim, Boris Kerzner, Wang Xueyan, Harold E. Bays, Sherwyn Schwartz
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 96:2889-2897
Preclinical and clinical studies suggest that peroxisome proliferator-activated receptor (PPAR)-δ agonists favorably affect multiple metabolic parameters that are otherwise proatherogenic, many that are not optimally managed with statins alone.The a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::575284ca63b8af6323cc013411a8de47
https://doi.org/10.1210/jc.2011-1061
https://doi.org/10.1210/jc.2011-1061
Autor:
Jon E. Stek, Rudy Ifle, Florian P Schödel, Mark Tomlinson, Katia Schlienger, Julie L Barben, Kimberly Rarrick, Mi-Ok Chung, Alexander V Murray, William W B Wang, Boris Kerzner, Jin Xu, Eric Cheng, Jeffrey L Silber, Peter R Harvey, Ivan S F Chan
Publikováno v:
Journal of the American Geriatrics Society. 55:1499-1507
OBJECTIVES: To evaluate the safety and immunogenicity of ZOSTAVAX administered concomitantly with inactivated influenza vaccine or sequentially in adults aged 50 and older. DESIGN: Randomized, blinded, placebo-controlled study. SETTING: Thirteen U.S.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f52fca5a4c44162a978ab921b0e5ee1d
https://doi.org/10.1111/j.1532-5415.2007.01397.x
https://doi.org/10.1111/j.1532-5415.2007.01397.x
Autor:
Boris, Kerzner, Alexander V, Murray, Eric, Cheng, Rudy, Ifle, Peter R, Harvey, Mark, Tomlinson, Julie L, Barben, Kimberly, Rarrick, Jon E, Stek, Mi-Ok, Chung, Florian P, Schödel, William W B, Wang, Jin, Xu, Ivan S F, Chan, Jeffrey L, Silber, Katia, Schlienger
Publikováno v:
Journal of the American Geriatrics Society. 55(10)
To evaluate the safety and immunogenicity of ZOSTAVAX administered concomitantly with inactivated influenza vaccine or sequentially in adults aged 50 and older.Randomized, blinded, placebo-controlled study.Thirteen U.S. and seven European study sites
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::678b7c781c2dc70e6ad98825d1d8f954
https://pubmed.ncbi.nlm.nih.gov/17908055
https://pubmed.ncbi.nlm.nih.gov/17908055
Autor:
Lorenzo Melani, John Corbelli, Leslie Lipka, Enrico P. Veltri, Alexandre LeBeaut, Stephan Sharp, Pabak Mukhopadhyay, Ramachandran Suresh, Boris Kerzner
Publikováno v:
The American journal of cardiology. 91(4)
This multicenter, randomized, double-blind, placebo-controlled clinical study assessed the efficacy and safety of ezetimibe administered with lovastatin in primary hypercholesterolemia. After dietary stabilization, a 2- to 12-week washout period, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cbf2c8dea9af6b2779f7560cf55bff1
https://pubmed.ncbi.nlm.nih.gov/12586255
https://pubmed.ncbi.nlm.nih.gov/12586255
Autor:
Moti L, Kashyap, Mark E, McGovern, Kathleen, Berra, John R, Guyton, Peter O, Kwiterovich, Wayne L, Harper, Phillip D, Toth, Laurence K, Favrot, Boris, Kerzner, Stephen D, Nash, Harold E, Bays, Phillip D, Simmons
Publikováno v:
The American journal of cardiology. 89(6)
Combination therapy is increasingly recommended for patients with multiple lipid disorders, especially those at high risk for coronary events. We investigated the long-term safety and effectiveness of a new drug formulation containing once-daily exte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b8fc79021f4e1970b4e85a8c68e9f5f2
https://pubmed.ncbi.nlm.nih.gov/11897208
https://pubmed.ncbi.nlm.nih.gov/11897208
Publikováno v:
Clinical Pharmacology & Therapeutics. 23:451-455
The interaction of lithium and chlorpromazine (CPZ) was studied in healthy volunteers in a randomized crossover study. Each subject ingested two doses of CPZ (100 mg) as the liquid concentrate: (1) without concurrent lithium therapy and (2) after a 7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73339bcbcdf9b0a18a92e4806cee6f54
https://doi.org/10.1002/cpt1978234451
https://doi.org/10.1002/cpt1978234451
Autor:
Michael Weintraub, Fred E. Karch, Boris Kerzner, Carol L. Smith, Louis Lasagna, John M. Mazzullo
Publikováno v:
Clinical Pharmacology & Therapeutics. 19:489-492
The accurate identification of adverse drug reactions (ADRs) is difficult because ADRs usually present no unique clinical or laboratory findings that demarcate them from the manifestations of concurrent illnesses. The identification of ADRs depends o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::caa27c82173622adc6dc53ce99ecd88f
https://doi.org/10.1002/cpt1976195part1489
https://doi.org/10.1002/cpt1976195part1489